MusthInsider

Latest On Apellis Pharmaceuticals, Inc (APLS):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-25 17:48 EST	News	Apellis and Sobi to drop ALS candidate on Phase 2 setback	N/A
2023-05-18 17:01 EST	News	Apellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition Space	N/A
2023-05-06 12:27 EST	News	Apellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call Presentation	N/A
2023-05-06 12:27 EST	News	Apellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call Transcript	N/A
2023-05-04 22:14 EST	News	Apellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric Bio	N/A
2023-05-04 22:14 EST	News	Apellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74M	N/A
2023-05-03 20:58 EST	News	Apellis Pharmaceuticals Q1 2023 Earnings Preview	N/A
2023-05-01 19:14 EST	News	Apellis weakness on Iveric Bio takeout is buying opportunity - analyst	N/A
2023-05-01 06:55 EST	News	Apellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - Slideshow	N/A
2023-04-03 17:26 EST	News	Apellis Pharmaceuticals may be worth $90-$100 a share in sale - analyst	N/A
2023-04-02 23:22 EST	News	Apellis Pharmaceuticals sees takeover interest from large pharma - Bloomberg	N/A
2023-03-24 22:48 EST	News	Apellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy Market	N/A
2023-03-16 14:19 EST	News	Apellis Pharmaceuticals' Empaveli sNDA action date extended by FDA	N/A
2023-02-23 11:44 EST	News	Apellis Pharmaceuticals prices $350M in stock offering	N/A
2023-02-22 09:58 EST	News	Apellis Pharmaceuticals to raise $300M in stock and warrants offering	N/A
2023-02-21 21:29 EST	News	Apellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86M	N/A
2023-02-18 02:43 EST	News	Apellis wins FDA nod for eye disorder therapy	N/A
2023-01-27 18:43 EST	News	Apellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks Bright	N/A
2023-01-21 14:26 EST	News	Stocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A Wildcards	N/A
2023-01-05 20:02 EST	News	Apellis appoints Baumal as Chief Medical Officer	N/A
2023-01-04 02:30 EST	News	Apellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech preview	N/A
2022-12-15 23:44 EST	News	Apellis Pharmaceuticals: Approval Is Baked Into Valuation	N/A
2022-11-18 10:24 EST	News	Apellis surges 17% as FDA accepts to review new data in filing for eye disorder drug	N/A
2022-11-11 06:07 EST	News	Apellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA market	N/A
2022-11-08 08:01 EST	News	Apellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46M	N/A
2022-11-08 08:00 EST	News	Apellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call Transcript	N/A
2022-11-05 08:22 EST	News	Apellis Pharmaceuticals Q3 2022 Earnings Preview	N/A
2022-11-03 23:08 EST	News	Apellis sinks 20% as FDA review period for eye disease drug extends	N/A
2022-10-16 23:00 EST	News	Citi lists four more value-creating events in biotech for this year	N/A
2022-09-29 06:33 EST	News	Apellis Pharmaceuticals: Trying To Develop A Blockbuster Franchise	N/A
2022-09-08 07:22 EST	News	Apellis gains as FDA says AdCom unnecessary for eye disease candidate	N/A
2022-08-24 16:51 EST	News	Apellis stock dips amid 2-year data of pegcetacoplan for eye disorder	N/A
2022-08-09 18:37 EST	News	Apellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call Presentation	N/A
2022-08-09 18:37 EST	News	Apellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call Transcript	N/A
2022-08-08 18:56 EST	News	Apellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63M	N/A
2022-08-06 06:05 EST	News	Apellis Pharmaceuticals Q2 2022 Earnings Preview	N/A
2022-07-27 15:50 EST	News	Apellis to exchange $75.6M in convertible senior notes for common stock	N/A
2022-07-20 18:36 EST	News	Apellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic Atrophy	N/A
2022-07-20 03:57 EST	News	Wainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%	N/A
2022-07-19 13:21 EST	News	Apellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorder	N/A
2022-07-19 13:19 EST	News	H.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degeneration	N/A
2022-06-25 15:25 EST	News	Apellis: Mixed Data, But Definitely Approvable In GA	N/A
2022-06-13 19:55 EST	News	Hot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plunged	N/A
2022-06-10 11:34 EST	News	Apellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analyses	N/A
2022-06-01 11:05 EST	News	Apellis files for FDA approval of pegcetacoplan to treat eye disorder	N/A
2022-05-06 19:17 EST	News	Apellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation	N/A
2022-05-06 19:15 EST	News	Apellis Pharmaceuticals (APLS) Investor Presentation - Slideshow	N/A
2022-05-04 22:43 EST	News	Apellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52M	N/A
2022-05-04 22:42 EST	News	Apellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call Transcript	N/A
2022-05-04 03:15 EST	News	Apellis Pharmaceuticals Q1 2022 Earnings Preview	N/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

Name Apellis Pharmaceuticals, Inc
Symbol APLS
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 374
Fiscal Year EndDecember
IPO Date2017-11-09
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.apellis.com

Valuation

Price/Sales (Trailing 12 Mt.) 13.99
Price/Book (Most Recent Quarter) 18.33
Enterprise Value Revenue 12.97

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$6.46
Next Year EPS Estimate -$5.31
Next Quarter EPS Estimate -$1.60
Profit Margin -138%
Operating Margin -85%
Return on Assets -20%
Return on Equity -289%
Revenue 250.65 million
Earnings Per Share -$3.32
Revenue Per Share $3.34
Gross Profit -74325000
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 3.54 billion
Analyst Target Price $64.14
Book Value Per Share $2.69

Share Statistics

Shares Outstanding 80.38 million
Shares Float 59.7 million
% Held by Insiders 2117%
% Held by Institutions 82.85%
Shares Short 8.11 million
Shares Short Prior Month 7.75 million
Short Ratio 13.44
Short % of Float 15%
Short % of Shares Outstanding 10%

Technicals

Beta 1.52
52 Week High $58.47
52 Week Low $21.84
50 Day Moving Average 46.47
200 Day Moving Average 42.62

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-02-25	$N/A	$0.93	-$0.45	304.58%
2020-09-30	2020-11-02	$646000	-$1.79	-$1.58	-13.31%
2020-06-30	2020-07-30	$N/A	-$1.57	-$1.34	-17.56%
2020-03-31	2020-04-29	$N/A	-$2.29	-$1.39	-64.72%
2019-12-31	2020-02-27	$N/A	-$1.77	-$1.14	-55%
2019-09-30	2019-11-05	$N/A	-$1.10	-$1.03	-6.44%
2019-06-30	2019-07-31	$N/A	-$1.12	-$0.78	-44.39%
2019-03-31	2019-05-07	$N/A	-$0.87	-$0.68	-27.49%
2018-12-31	2019-02-26	$N/A	-$0.65	-$0.70	7.58%
2018-09-30	2018-11-13	$N/A	-$0.64	-$0.69	7.02%
2018-06-30	2018-07-31	$N/A	-$0.61	-$0.42	-45.86%
2018-03-31	2018-04-30	$N/A	-$0.43	-$0.27	-57.28%
2017-12-31	2018-03-19	$N/A	-$0.61	-$0.27	-129.32%
2017-09-30	2017-12-20	$N/A	-$0.23	-$0.24	2.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2026-03-20	13	0	CALL	0	0	0	TRUE	0	0
2026-03-20	14	0	CALL	0	0	0	TRUE	0	0
2026-03-20	15	6.6	CALL	0	1	0	TRUE	0	0
2026-03-20	16	0	CALL	0	0	69.5	TRUE	0	0
2026-03-20	17	0	CALL	0	0	0	TRUE	0	0
2026-03-20	18	3.7	CALL	0	1	0	TRUE	0	0
2026-03-20	19	0	CALL	0	0	59.06	TRUE	0	0
2026-03-20	20	3.2	CALL	0	1	67.54	TRUE	0	0
2026-03-20	21	1.75	CALL	0	1	47.24	FALSE	0	0
2026-03-20	22	0.6	CALL	18	209	51.03	FALSE	-0.4	-0.4
2026-03-20	23	0.3	CALL	4	21	48.58	FALSE	-0.27	-0.47
2026-03-20	24	0.38	CALL	0	391	74.62	FALSE	0	0
2026-03-20	25	0.15	CALL	0	127	126.12	FALSE	0	0
2026-03-20	26	0.2	CALL	0	75	195.79	FALSE	0	0
2026-03-20	27	0.15	CALL	0	10	208.09	FALSE	0	0
2026-03-20	28	0	CALL	0	0	216.85	FALSE	0	0
2026-03-20	29	0	CALL	0	0	227.53	FALSE	0	0
2026-03-20	30	0.2	CALL	0	8	110.76	FALSE	0	0
2026-03-20	31	0	CALL	0	0	247.04	FALSE	0	0
2026-03-20	13	0	PUT	0	0	343.08	FALSE	0	0
2026-03-20	14	0	PUT	0	0	308.96	FALSE	0	0
2026-03-20	15	0	PUT	0	0	277.18	FALSE	0	0
2026-03-20	16	0	PUT	0	0	247.25	FALSE	0	0
2026-03-20	17	0.2	PUT	0	1	221.94	FALSE	0	0
2026-03-20	18	0.17	PUT	0	131	58.69	FALSE	0	0
2026-03-20	19	0	PUT	0	0	83.18	FALSE	0	0
2026-03-20	20	0.4	PUT	0	1609	64.68	FALSE	0	0
2026-03-20	21	0.65	PUT	0	39	45.91	TRUE	0	0
2026-03-20	22	1.5	PUT	1	0	45.51	TRUE	1.5	0
2026-03-20	23	1.85	PUT	0	52	56.53	TRUE	0	0
2026-03-20	24	0	PUT	0	0	0	TRUE	0	0
2026-03-20	25	0	PUT	0	0	0	TRUE	0	0
2026-03-20	26	0	PUT	0	0	0	TRUE	0	0
2026-03-20	27	0	PUT	0	0	0	TRUE	0	0
2026-03-20	28	0	PUT	0	0	62.9	TRUE	0	0
2026-03-20	29	0	PUT	0	0	69.22	TRUE	0	0
2026-03-20	30	7	PUT	0	0	0	TRUE	0	0
2026-03-20	31	0	PUT	0	0	0	TRUE	0	0
2026-04-17	10	0	CALL	0	0	101.26	TRUE	0	0
2026-04-17	11	12	CALL	0	280	0	TRUE	0	0
2026-04-17	12	0	CALL	0	0	0	TRUE	0	0
2026-04-17	13	0	CALL	0	0	0	TRUE	0	0
2026-04-17	14	7	CALL	0	1	93.73	TRUE	0	0
2026-04-17	15	7.6	CALL	0	26	91.7	TRUE	0	0
2026-04-17	16	6.35	CALL	0	2	57.11	TRUE	0	0
2026-04-17	17	4.5	CALL	0	2	74.07	TRUE	0	0
2026-04-17	18	9.28	CALL	0	309	53.97	TRUE	0	0
2026-04-17	19	3.74	CALL	0	3	62.24	TRUE	0	0
2026-04-17	20	2.29	CALL	0	631	52.15	TRUE	0	0
2026-04-17	21	1.84	CALL	0	58	72.66	FALSE	0	0
2026-04-17	22	1.45	CALL	0	119	77.29	FALSE	0	0
2026-04-17	23	2.44	CALL	0	25	65.55	FALSE	0	0
2026-04-17	24	1.15	CALL	0	56	127.61	FALSE	0	0
2026-04-17	25	0.59	CALL	0	90	87.97	FALSE	0	0
2026-04-17	26	1	CALL	0	193	83.17	FALSE	0	0
2026-04-17	27	0.5	CALL	0	56	96.23	FALSE	0	0
2026-04-17	28	1	CALL	0	10	95.14	FALSE	0	0
2026-04-17	29	1.45	CALL	0	1	153.24	FALSE	0	0
2026-04-17	30	0.5	CALL	0	962	129.19	FALSE	0	0
2026-04-17	31	1.62	CALL	0	32	162.47	FALSE	0	0
2026-04-17	32	1.5	CALL	0	10	168.3	FALSE	0	0
2026-04-17	33	0.33	CALL	0	10	173.83	FALSE	0	0
2026-04-17	34	1.25	CALL	0	26	177.31	FALSE	0	0
2026-04-17	35	0.45	CALL	0	37	182.33	FALSE	0	0
2026-04-17	36	1.6	CALL	0	1	187.13	FALSE	0	0
2026-04-17	37	0.65	CALL	0	2	176.71	FALSE	0	0
2026-04-17	38	0.65	CALL	0	3	181.04	FALSE	0	0
2026-04-17	39	0.65	CALL	0	5	185.2	FALSE	0	0
2026-04-17	40	2	CALL	0	4	181.22	FALSE	0	0
2026-04-17	41	0.5	CALL	0	10	176.67	FALSE	0	0
2026-04-17	45	0.45	CALL	0	20	219.09	FALSE	0	0
2026-04-17	10	0.65	PUT	0	2	298.33	FALSE	0	0
2026-04-17	11	0.7	PUT	0	6	269.26	FALSE	0	0
2026-04-17	12	0.8	PUT	0	10	243.2	FALSE	0	0
2026-04-17	13	0.2	PUT	0	5	117.86	FALSE	0	0
2026-04-17	14	0	PUT	0	0	200.2	FALSE	0	0
2026-04-17	15	0.3	PUT	0	3	182.04	FALSE	0	0
2026-04-17	16	2	PUT	0	14	80.86	FALSE	0	0
2026-04-17	17	0.1	PUT	0	12	152.29	FALSE	0	0
2026-04-17	18	0.84	PUT	0	1412	73.09	FALSE	0	0
2026-04-17	19	0.96	PUT	0	83	64.14	FALSE	0	0
2026-04-17	20	1	PUT	5	718	49.59	FALSE	1	0
2026-04-17	21	1.62	PUT	0	49	54.54	TRUE	0	0
2026-04-17	22	1.95	PUT	0	392	48.51	TRUE	0	0
2026-04-17	23	3.12	PUT	0	18	48.34	TRUE	0	0
2026-04-17	24	2.9	PUT	0	21	51.86	TRUE	0	0
2026-04-17	25	4.8	PUT	0	45	62.05	TRUE	0	0
2026-04-17	26	4.21	PUT	0	0	60.42	TRUE	0	0
2026-04-17	27	4.8	PUT	0	27	51.76	TRUE	0	0
2026-04-17	28	0	PUT	0	0	0	TRUE	0	0
2026-04-17	29	7.05	PUT	0	1	0	TRUE	0	0
2026-04-17	30	5.7	PUT	0	311	0	TRUE	0	0
2026-04-17	31	11.9	PUT	0	2	0	TRUE	0	0
2026-04-17	32	7.1	PUT	0	2	0	TRUE	0	0
2026-04-17	33	7.3	PUT	0	1	74.61	TRUE	0	0
2026-04-17	34	0	PUT	0	0	0	TRUE	0	0
2026-04-17	35	0	PUT	0	0	72.74	TRUE	0	0
2026-04-17	36	0	PUT	0	0	76.11	TRUE	0	0
2026-04-17	37	0	PUT	0	0	79.38	TRUE	0	0
2026-04-17	38	0	PUT	0	0	82.55	TRUE	0	0
2026-04-17	39	0	PUT	0	0	85.62	TRUE	0	0
2026-04-17	40	0	PUT	0	0	88.61	TRUE	0	0
2026-04-17	41	0	PUT	0	0	91.51	TRUE	0	0
2026-04-17	45	0	PUT	0	0	102.3	TRUE	0	0
2026-07-17	12	0	CALL	0	0	74.96	TRUE	0	0
2026-07-17	13	9.5	CALL	0	1	70.73	TRUE	0	0
2026-07-17	14	0	CALL	0	0	70.08	TRUE	0	0
2026-07-17	15	0	CALL	0	0	68.02	TRUE	0	0
2026-07-17	16	0	CALL	0	0	67.92	TRUE	0	0
2026-07-17	17	6.62	CALL	0	1	65.21	TRUE	0	0
2026-07-17	18	0	CALL	0	0	65.27	TRUE	0	0
2026-07-17	19	0	CALL	0	0	65.8	TRUE	0	0
2026-07-17	20	5.4	CALL	0	17	66.25	TRUE	0	0
2026-07-17	21	4.9	CALL	0	9	66.2	FALSE	0	0
2026-07-17	22	3.1	CALL	0	1	64.79	FALSE	0	0
2026-07-17	23	4.5	CALL	0	2	65.49	FALSE	0	0
2026-07-17	24	2.45	CALL	0	1	67.38	FALSE	0	0
2026-07-17	25	3.33	CALL	0	1	65.16	FALSE	0	0
2026-07-17	26	2.7	CALL	0	69	67.24	FALSE	0	0
2026-07-17	27	0	CALL	0	0	103	FALSE	0	0
2026-07-17	28	2.15	CALL	0	50	77.78	FALSE	0	0
2026-07-17	29	0	CALL	0	0	103.91	FALSE	0	0
2026-07-17	30	1.6	CALL	0	39	104.9	FALSE	0	0
2026-07-17	31	1.6	CALL	0	1	108.63	FALSE	0	0
2026-07-17	32	1.5	CALL	0	1	110.15	FALSE	0	0
2026-07-17	33	0	CALL	0	0	82.54	FALSE	0	0
2026-07-17	34	0	CALL	0	0	111.58	FALSE	0	0
2026-07-17	35	1	CALL	0	3	85.91	FALSE	0	0
2026-07-17	36	0	CALL	0	0	114.35	FALSE	0	0
2026-07-17	37	0	CALL	0	0	116.04	FALSE	0	0
2026-07-17	38	0	CALL	0	0	94.87	FALSE	0	0
2026-07-17	39	0	CALL	0	0	120.13	FALSE	0	0
2026-07-17	40	0	CALL	0	0	104.45	FALSE	0	0
2026-07-17	12	0	PUT	0	0	153.01	FALSE	0	0
2026-07-17	13	0	PUT	0	0	141.61	FALSE	0	0
2026-07-17	14	1.15	PUT	0	2	136.84	FALSE	0	0
2026-07-17	15	1.3	PUT	0	1	129.08	FALSE	0	0
2026-07-17	16	1.35	PUT	0	1	122.77	FALSE	0	0
2026-07-17	17	1.72	PUT	0	1	117.61	FALSE	0	0
2026-07-17	18	1.97	PUT	0	1	86.53	FALSE	0	0
2026-07-17	19	1.83	PUT	0	3	63.82	FALSE	0	0
2026-07-17	20	2.15	PUT	0	10	65.09	FALSE	0	0
2026-07-17	21	2.75	PUT	0	9	61.29	TRUE	0	0
2026-07-17	22	3.9	PUT	0	20	62.07	TRUE	0	0
2026-07-17	23	3.65	PUT	0	10	63.9	TRUE	0	0
2026-07-17	24	4.2	PUT	0	10	62.97	TRUE	0	0
2026-07-17	25	4.85	PUT	0	25	62.75	TRUE	0	0
2026-07-17	26	0	PUT	0	0	63.86	TRUE	0	0
2026-07-17	27	0	PUT	0	0	63.32	TRUE	0	0
2026-07-17	28	0	PUT	0	0	62.08	TRUE	0	0
2026-07-17	29	0	PUT	0	0	53.37	TRUE	0	0
2026-07-17	30	9.2	PUT	0	0	63.69	TRUE	0	0
2026-07-17	31	0	PUT	0	0	63.09	TRUE	0	0
2026-07-17	32	0	PUT	0	0	58.53	TRUE	0	0
2026-07-17	33	0	PUT	0	0	45.52	TRUE	0	0
2026-07-17	34	0	PUT	0	0	62.4	TRUE	0	0
2026-07-17	35	0	PUT	0	0	63.04	TRUE	0	0
2026-07-17	36	0	PUT	0	0	60.66	TRUE	0	0
2026-07-17	37	0	PUT	0	0	0	TRUE	0	0
2026-07-17	38	0	PUT	0	0	0	TRUE	0	0
2026-07-17	39	0	PUT	0	0	0	TRUE	0	0
2026-07-17	40	0	PUT	0	0	60.88	TRUE	0	0
2026-10-16	14	0	CALL	0	0	70.09	TRUE	0	0
2026-10-16	15	0	CALL	0	0	66.6	TRUE	0	0
2026-10-16	16	0	CALL	0	0	72.29	TRUE	0	0
2026-10-16	17	0	CALL	0	0	66.61	TRUE	0	0
2026-10-16	18	0	CALL	0	0	69.05	TRUE	0	0
2026-10-16	19	0	CALL	0	0	65.42	TRUE	0	0
2026-10-16	20	0	CALL	0	0	66.79	TRUE	0	0
2026-10-16	21	0	CALL	0	0	65.91	FALSE	0	0
2026-10-16	22	0	CALL	0	0	64.54	FALSE	0	0
2026-10-16	23	0	CALL	0	0	62.72	FALSE	0	0
2026-10-16	24	0	CALL	0	0	59.71	FALSE	0	0
2026-10-16	25	0	CALL	0	0	61.15	FALSE	0	0
2026-10-16	26	0	CALL	0	0	60.67	FALSE	0	0
2026-10-16	27	0	CALL	0	0	61.71	FALSE	0	0
2026-10-16	28	0	CALL	0	0	61.64	FALSE	0	0
2026-10-16	29	0	CALL	0	0	63.25	FALSE	0	0
2026-10-16	30	0	CALL	0	0	65.43	FALSE	0	0
2026-10-16	14	0	PUT	0	0	120.14	FALSE	0	0
2026-10-16	15	0	PUT	0	0	115.44	FALSE	0	0
2026-10-16	16	0	PUT	0	0	110.72	FALSE	0	0
2026-10-16	17	0	PUT	0	0	68.94	FALSE	0	0
2026-10-16	18	0	PUT	0	0	65.26	FALSE	0	0
2026-10-16	19	0	PUT	0	0	62.99	FALSE	0	0
2026-10-16	20	0	PUT	0	0	61.06	FALSE	0	0
2026-10-16	21	0	PUT	0	0	62.55	TRUE	0	0
2026-10-16	22	0	PUT	0	0	61.47	TRUE	0	0
2026-10-16	23	0	PUT	0	0	60.26	TRUE	0	0
2026-10-16	24	0	PUT	0	0	59.69	TRUE	0	0
2026-10-16	25	0	PUT	0	0	60.53	TRUE	0	0
2026-10-16	26	0	PUT	0	0	57.84	TRUE	0	0
2026-10-16	27	0	PUT	0	0	58.57	TRUE	0	0
2026-10-16	28	0	PUT	0	0	59.74	TRUE	0	0
2026-10-16	29	0	PUT	0	0	61.43	TRUE	0	0
2026-10-16	30	0	PUT	0	0	62.89	TRUE	0	0
2027-01-15	5	15.1	CALL	0	4	82.66	TRUE	0	0
2027-01-15	10	11.6	CALL	5	19	61.14	TRUE	11.6	0
2027-01-15	13	10.8	CALL	0	6	69.72	TRUE	0	0
2027-01-15	15	8	CALL	10	2287	61.59	TRUE	8	0
2027-01-15	18	0	CALL	0	0	67.92	TRUE	0	0
2027-01-15	20	5.82	CALL	0	82	62.75	TRUE	0	0
2027-01-15	23	6.27	CALL	0	75	68.37	FALSE	0	0
2027-01-15	25	3.4	CALL	0	46	62.43	FALSE	0	0
2027-01-15	28	4.3	CALL	0	8	62.58	FALSE	0	0
2027-01-15	30	4.05	CALL	0	211	65.73	FALSE	0	0
2027-01-15	33	0.95	CALL	0	5	70.1	FALSE	0	0
2027-01-15	35	2.31	CALL	0	2562	67.66	FALSE	0	0
2027-01-15	37	3.1	CALL	0	1	97.69	FALSE	0	0
2027-01-15	40	2.55	CALL	0	251	101.62	FALSE	0	0
2027-01-15	42	1.4	CALL	0	2690	77.87	FALSE	0	0
2027-01-15	45	2.17	CALL	0	49	80.51	FALSE	0	0
2027-01-15	47	2.43	CALL	0	1	109.23	FALSE	0	0
2027-01-15	50	0.7	CALL	0	54	91.51	FALSE	0	0
2027-01-15	55	0.27	CALL	0	399	104.18	FALSE	0	0
2027-01-15	5	0	PUT	0	0	300.51	FALSE	0	0
2027-01-15	10	0.7	PUT	0	1	159.6	FALSE	0	0
2027-01-15	13	0	PUT	0	0	123.6	FALSE	0	0
2027-01-15	15	2.6	PUT	0	199	109.83	FALSE	0	0
2027-01-15	18	2.75	PUT	0	7	63.43	FALSE	0	0
2027-01-15	20	3.8	PUT	0	118	63.47	FALSE	0	0
2027-01-15	23	5.55	PUT	0	3	61.02	TRUE	0	0
2027-01-15	25	5.6	PUT	0	700	68.77	TRUE	0	0
2027-01-15	28	6.41	PUT	0	5	61.69	TRUE	0	0
2027-01-15	30	9.5	PUT	0	1031	62.14	TRUE	0	0
2027-01-15	33	16.37	PUT	0	5	62.53	TRUE	0	0
2027-01-15	35	16.71	PUT	0	637	56.38	TRUE	0	0
2027-01-15	37	0	PUT	0	0	53.05	TRUE	0	0
2027-01-15	40	19.84	PUT	0	1	52.36	TRUE	0	0
2027-01-15	42	0	PUT	0	2	0	TRUE	0	0
2027-01-15	45	0	PUT	0	0	0	TRUE	0	0
2027-01-15	47	0	PUT	0	0	0	TRUE	0	0
2027-01-15	50	0	PUT	0	0	0	TRUE	0	0
2027-01-15	55	0	PUT	0	0	0	TRUE	0	0
2028-01-21	10	12.4	CALL	0	28	64.24	TRUE	0	0
2028-01-21	13	13.44	CALL	0	3	64.22	TRUE	0	0
2028-01-21	15	0	CALL	0	0	64.26	TRUE	0	0
2028-01-21	18	10	CALL	0	1	62.03	TRUE	0	0
2028-01-21	20	10.5	CALL	0	7	59.63	TRUE	0	0
2028-01-21	22	0	CALL	0	0	61.48	FALSE	0	0
2028-01-21	25	8.25	CALL	0	1	60.46	FALSE	0	0
2028-01-21	27	7.19	CALL	0	2	60.6	FALSE	0	0
2028-01-21	30	9.6	CALL	0	3	57.78	FALSE	0	0
2028-01-21	32	0	CALL	0	0	56.85	FALSE	0	0
2028-01-21	35	4	CALL	0	863	56.52	FALSE	0	0
2028-01-21	37	0	CALL	0	0	59.62	FALSE	0	0
2028-01-21	40	3.1	CALL	0	6	63.22	FALSE	0	0
2028-01-21	45	2.6	CALL	0	10	81.62	FALSE	0	0
2028-01-21	10	0	PUT	0	0	141.05	FALSE	0	0
2028-01-21	13	0	PUT	0	0	105.39	FALSE	0	0
2028-01-21	15	2.5	PUT	0	4	62.38	FALSE	0	0
2028-01-21	18	0	PUT	0	0	62.06	FALSE	0	0
2028-01-21	20	0	PUT	0	0	60.58	FALSE	0	0
2028-01-21	22	0	PUT	0	0	63.16	TRUE	0	0
2028-01-21	25	0	PUT	0	0	58.55	TRUE	0	0
2028-01-21	27	0	PUT	0	0	59.32	TRUE	0	0
2028-01-21	30	12.63	PUT	0	0	57.19	TRUE	0	0
2028-01-21	32	0	PUT	0	0	56.6	TRUE	0	0
2028-01-21	35	0	PUT	0	0	57.26	TRUE	0	0
2028-01-21	37	0	PUT	0	0	55.42	TRUE	0	0
2028-01-21	40	0	PUT	0	0	54.31	TRUE	0	0
2028-01-21	45	0	PUT	0	0	54.01	TRUE	0	0

Latest APLS Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	5	$39.4
Jun 13, 2022 7:59 PM EST	25	$39.4
Jun 13, 2022 7:59 PM EST	86	$39.39
Jun 13, 2022 7:59 PM EST	14	$39.4
Jun 13, 2022 7:59 PM EST	32	$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-05	3/A	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-06	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-06	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-06	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-27	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-09	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19	D	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-27	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-29	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-30	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-02	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2020-02-13	Pascal Deschatelets	Chief Operating Officer	Sell	55,398.00	40.98	2,270,154.64	1,008,681.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18	Cedric Francois	Chief Executive Officer	Sell	5,000.00	40.67	203,330.00	1,027,430.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18	Cedric Francois	Chief Executive Officer	Sell	30,637.00	40.66	1,245,792.33	1,032,430.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Sell	300.00	23.86	7,158.00	1,053,067.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Sell	3,212.00	22.28	71,556.94	1,053,367.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Sell	15,065.00	21.58	325,087.64	1,056,579.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19	Cedric Francois	Chief Executive Officer	Buy	30,637.00	2.14	65,563.18	1,058,067.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18	Cedric Francois	Chief Executive Officer	Buy	30,637.00	2.14	65,563.18	1,063,067.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13	Pascal Deschatelets	Chief Operating Officer	Buy	117,205.00	2.14	250,818.70	1,064,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10	Cedric Francois	Chief Executive Officer	Buy	34,375.00			1,066,805.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Sell	12,060.00	20.69	249,557.58	1,071,644.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15	Cedric Francois	Chief Executive Officer	Sell	5,000.00	34.46	172,300.00	1,083,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17	Cedric Francois	Chief Executive Officer	Buy	30,637.00	2.14	65,563.18	1,083,704.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Sell	700.00	22.29	15,600.20	1,083,704.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Sell	2,192.00	21.57	47,279.25	1,084,404.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Sell	2,108.00	20.73	43,694.62	1,086,596.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15	Cedric Francois	Chief Executive Officer	Sell	5,000.00	30.96	154,800.00	1,088,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16	Cedric Francois	Chief Executive Officer	Buy	30,637.00	2.14	65,563.18	1,088,704.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20	Cedric Francois	Chief Executive Officer	Sell	3,457.00	30.00	103,710.00	1,093,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18	Cedric Francois	Chief Executive Officer	Sell	1,543.00	30.00	46,290.00	1,096,536.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15	Cedric Francois	Chief Executive Officer	Sell	5,000.00	32.12	160,600.00	1,098,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15	Cedric Francois	Chief Executive Officer	Sell	5,000.00	30.21	151,050.00	1,103,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15	Cedric Francois	Chief Executive Officer	Sell	5,000.00	29.92	149,600.00	1,108,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15	Cedric Francois	Chief Executive Officer	Sell	5,000.00	29.77	148,850.00	1,113,079.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10	LUKAS SCHEIBLER	Officer	Buy	9,375.00			12,310.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07	Victoria L. Brown	Program Team Lead	Buy	12,000.00	18.98	227,760.00	15,607.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10	Timothy Eugene Sullivan	Chief Financial Officer	Buy	11,688.00			23,387.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10	Nicole D Perry	Vice President - Finance	Buy	2,500.00			2,500.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10	Ahmad Sadr	Officer	Buy	2,725.00			2,725.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02	Federico Grossi	CHIEF MEDICAL OFFICER	Sell	600.00	31.09	18,654.00	27,725.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01	Federico Grossi	Officer	Sell	600.00	30.22	18,132.00	28,325.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01	Federico Grossi	Officer	Sell	600.00	31.58	18,948.00	28,925.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03	Federico Grossi	Officer	Sell	600.00	26.28	15,768.00	29,525.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01	Federico Grossi	Officer	Sell	850.00	32.43	27,565.50	30,125.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15	Federico Grossi	Officer	Sell	856.00	30.21	25,859.76	30,975.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10	Federico Grossi	Officer	Buy	9,375.00			31,831.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10	David O. Watson	General Counsel	Sell	5,000.00	44.50	222,500.00	35,417.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07	Victoria L. Brown	Program Team Lead	Sell	12,000.00	35.00	420,000.00	3,607.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10	David O. Watson	General Counsel	Buy	6,375.00			40,417.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10	David O. Watson	General Counsel	Buy	7,505.00	2.67	20,038.35	42,922.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08	PAUL R. FONTEYNE	Director	Buy	5,000.00	31.81	159,034.00	5,000.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10	Lucia Celona	Officer	Buy	5,213.00			5,213.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14	Alec Machiels	Director	Sell	2,500.00	42.35	105,875.00	669,544.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25	Alec Machiels	Director	Sell	2,500.00	30.00	75,000.00	669,544.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15	Alec Machiels	Director	Sell	2,500.00	30.00	75,000.00	669,544.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15	Alec Machiels	Director	Sell	2,500.00	30.00	75,000.00	669,544.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15	Alec Machiels	Director	Sell	2,500.00	30.21	75,525.00	669,544.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07	Alec Machiels	Director	Sell	7,500.00	35.00	262,500.00	669,544.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15	Alec Machiels	Director	Sell	2,500.00	35.00	87,500.00	669,544.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14	Alec Machiels	Director	Buy	2,500.00	2.67	6,675.00	672,044.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25	Alec Machiels	Director	Buy	2,500.00	2.67	6,675.00	672,044.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15	Alec Machiels	Director	Buy	2,500.00	2.67	6,675.00	672,044.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15	Alec Machiels	Director	Buy	2,500.00	2.67	6,675.00	672,044.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15	Alec Machiels	Director	Buy	2,500.00	2.67	6,675.00	672,044.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15	Alec Machiels	Director	Buy	2,500.00	2.67	6,675.00	672,044.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07	Alec Machiels	Director	Buy	7,500.00	2.67	20,025.00	677,044.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10	Thomas A. Lackner	Officer	Buy	2,725.00			7,725.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10	Pascal Deschatelets	Chief Operating Officer	Buy	9,375.00			891,118.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10	Adam J. Townsend	Officer	Buy	9,375.00			9,375.00	https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12	Pascal Deschatelets	Chief Operating Officer	Sell	52,075.00	42.80	2,228,966.23	946,874.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12	Pascal Deschatelets	Chief Operating Officer	Buy	117,206.00	2.14	250,820.84	998,949.00	https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm

Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)